Page last updated: 2024-10-25

deferoxamine and Infarct

deferoxamine has been researched along with Infarct in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nankivell, BJ1
Chen, J1
Boadle, RA1
Harris, DC1
Roberts, RJ1
Nayfield, S1
Soper, R1
Kent, TH1

Other Studies

2 other studies available for deferoxamine and Infarct

ArticleYear
The role of tubular iron accumulation in the remnant kidney.
    Journal of the American Society of Nephrology : JASN, 1994, Volume: 4, Issue:8

    Topics: Animals; Creatinine; Deferoxamine; Disease Models, Animal; Electron Probe Microanalysis; Ferric Comp

1994
Acute iron intoxication with intestinal infarction managed in part by small bowel resection.
    Clinical toxicology, 1975, Volume: 8, Issue:1

    Topics: Deferoxamine; Humans; Ileostomy; Infant; Infarction; Intestinal Diseases; Intestine, Small; Iron; Ma

1975